We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Tool Rapidly Analyzes Complex Cancer Images for Personalized Treatment

By LabMedica International staff writers
Posted on 05 Dec 2025

Complex digital biopsy images that typically take an expert pathologist up to 20 minutes to assess can now be analyzed in about one minute using a new artificial intelligence (AI) tool. More...

The technology can detect cancer, identify where tumor lesions are located, and estimate the proportions of regions with varying aggressiveness. It offers a faster, more informative way to interpret tissue samples and could support more personalized treatment decisions.

The AI model, developed by researchers at the University of Cambridge (Cambridge, England, UK), was trained only on slides labeled with basic diagnostic information rather than detailed annotations. Using Superpatch-based Measurable Multiple Instance Learning, the system analyzes whole-slide images to map cancer subtypes and grade distributions, even though it was trained without region-level guidance. By capturing the heterogeneous composition of tumors, the algorithm mimics how clinicians interpret complex tissue structures.

To evaluate performance, the team tested the model on eight datasets containing 3,850 whole-slide images representing lung, kidney, ovarian, breast, stomach, and prostate cancers. The study, published in Nature Cancer, showed that the tool delivered slide-level classification accuracy comparable to or better than nine leading AI systems. It also dramatically outperformed them in estimating tumor subtype proportions and spatial distribution across tissues.

These findings suggest that the tool could streamline diagnostic workflows and expand access to advanced cancer profiling. Because it trains on inexpensive, widely available datasets, it may help overcome cost barriers associated with spatial tumor mapping. The team now plans to apply the system to predict molecular biomarkers, providing deeper insights into tumor biology and enabling more tailored treatment strategies.

“By allowing pathologists to make faster, more accurate diagnoses, we can make sure patients receive the best treatment even sooner, improving our chances of successfully treating their cancer,” said Dr. Zeyu Gao, Early Cancer Institute, University of Cambridge, developer of the algorithm.

Related Links:
University of Cambridge


Gold Member
Automatic CLIA Analyzer
Shine i9000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Homocysteine Quality Control
Liquichek Homocysteine Control
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Scout\'s patented molecular technology delivers results matching high-complexity PCR 99% of the time (Photo courtesy of Scout Health)

STI Molecular Test Delivers Rapid POC Results for Treatment Guidance

An affordable, rapid molecular diagnostic for sexually transmitted infections (STIs) has the potential to be globally relevant, particularly in resource-limited settings where rapid, point-of-care results... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.